These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3931649)

  • 1. Uptake in vitro of lipophilic model compounds into adipose tissue preparations and lipids.
    Di Francesco C; Bickel MH
    Biochem Pharmacol; 1985 Oct; 34(20):3683-8. PubMed ID: 3931649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of lipophilic model compounds into the isolated perfused rat epididymal adipose tissue.
    Gubser R; Di Francesco C; Bickel MH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):967-71. PubMed ID: 3086542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative adipose tissue kinetics of thiopental, DDE and 2,4,5,2',4',5'-hexachlorobiphenyl in the rat.
    Mühlebach S; Wyss PA; Bickel MH
    Xenobiotica; 1985 Jun; 15(6):485-91. PubMed ID: 3929482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of chlorpromazine and imipramine in adipose and other tissues of rats.
    Bickel MH; Graber BE; Moor M
    Life Sci; 1983 Nov; 33(20):2025-31. PubMed ID: 6645788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of adipose tissue in the distribution and storage of drugs.
    Bickel MH
    Prog Drug Res; 1984; 28():273-303. PubMed ID: 6435172
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in adipose tissue distribution of basic lipophilic drugs between intraperitoneal and other routes of administration.
    Betschart HR; Jondorf WR; Bickel MH
    Xenobiotica; 1988 Jan; 18(1):113-21. PubMed ID: 3354228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of 2,4,5,2',4',5'-hexachlorobiphenyl (6-CB) as an unmetabolizable lipophilic model compound.
    Mühlebach S; Wyss PA; Bickel MH
    Pharmacol Toxicol; 1991 Dec; 69(6):410-5. PubMed ID: 1766915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. I. Effects of restricting food intake two weeks after administration of 6-CB.
    Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1982; 10(6):657-61. PubMed ID: 6130918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution and half-lives of individual polychlorinated biphenyls and serum levels of 4-hydroxy-2,3,3',4',5-pentachlorobiphenyl in the rat.
    Oberg M; Sjödin A; Casabona H; Nordgren I; Klasson-Wehler E; Håkansson H
    Toxicol Sci; 2002 Dec; 70(2):171-82. PubMed ID: 12441362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
    Jondorf WR; Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1983; 11(6):597-601. PubMed ID: 6140146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partitioning of polychlorinated biphenyls into human cells and adipose tissues: evaluation of octanol, triolein, and liposomes as surrogates.
    Quinn CL; van der Heijden SA; Wania F; Jonker MT
    Environ Sci Technol; 2014 May; 48(10):5920-8. PubMed ID: 24806981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass.
    Wyss PA; Mühlebach S; Bickel MH
    Drug Metab Dispos; 1986; 14(3):361-5. PubMed ID: 2872039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms for redistribution of polychlorinated biphenyls during pregnancy and lactation.
    Gallenberg LA; Vodicnik MJ
    Xenobiotica; 1987 Mar; 17(3):299-310. PubMed ID: 3107224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in rats of 2,4,5,2',4',5'-hexachlorobiphenyl, an unmetabolizable lipophilic model compound.
    Mühlebach S; Bickel MH
    Xenobiotica; 1981 Apr; 11(4):249-57. PubMed ID: 6795836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of lipolysis on the mobilization of 2,4,5,2'4',5'-hexachlorobiphenyl from adipocytes in vitro.
    Gallenberg LA; Ring BJ; Vodicnik MJ
    J Toxicol Environ Health; 1987; 20(1-2):163-71. PubMed ID: 3100817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls.
    Parham FM; Kohn MC; Matthews HB; DeRosa C; Portier CJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):340-7. PubMed ID: 9194418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.
    Ishizaki J; Yokogawa K; Ichimura F; Ohkuma S
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1088-98. PubMed ID: 10945864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic study of the localization of 2,2', 4,4', 5,5'-hexachlorobiphenyl in liver and skin tissue after in vitro uptake.
    Di Francesco C; Gerber HA; Bickel MH
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):241-5. PubMed ID: 3149587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of distribution and elimination of DDE in rats.
    Mühlebach S; Moor MJ; Wyss PA; Bickel MH
    Xenobiotica; 1991 Jan; 21(1):111-20. PubMed ID: 2003362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of lysosomal trapping in the uptake of desipramine and chloroquine by different tissues.
    Daniel WA; Bickel MH; Honegger UE
    Pharmacol Toxicol; 1995 Dec; 77(6):402-6. PubMed ID: 8835367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.